CHMMF
Price:
$0.001
Market Cap:
$10.93M
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. It is also developing CHM 0301 for blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK) for solid tumors; CHM 1101 (CLTX CAR T) for melanoma, colorectal, and prostate; and CHM 2101 (CDH17 CAR T) for neuroendocrine, colorectal, pancreatic, and gastric. The compan...[Read more]
Industry
Biotechnology
IPO Date
2022-11-30
Stock Exchange
OTC
Ticker
CHMMF
According to Chimeric Therapeutics Limited’s latest financial reports and current stock price. The company's current ROE is -167.90%. This represents a change of -18.93% compared to the average of -207.11% of the last 4 quarters.
The mean historical ROE of Chimeric Therapeutics Limited over the last ten years is -252.53%. The current -167.90% ROE has changed -33.51% with respect to the historical average. Over the past ten years (40 quarters), CHMMF's ROE was at its highest in in the December 2020 quarter at 139.19%. The ROE was at its lowest in in the June 2024 quarter at -606.21%.
Average
-252.53%
Median
-259.84%
Minimum
-528.25%
Maximum
100.15%
Discovering the peaks and valleys of Chimeric Therapeutics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 640.28%
Maximum Annual ROE = 100.15%
Minimum Annual Increase = -160.05%
Minimum Annual ROE = -528.25%
| Year | ROE | Change |
|---|---|---|
| 2025 | -528.25% | 4.14% |
| 2024 | -507.27% | 10.80% |
| 2023 | -457.84% | 640.28% |
| 2022 | -61.85% | 2.84% |
| 2021 | -60.14% | -160.05% |
The current ROE of Chimeric Therapeutics Limited (CHMMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-497.79%
5-year avg
-323.07%
10-year avg
-252.53%
Chimeric Therapeutics Limited’s ROE is greater than Quantum Genomics S.A. (-156.81%), less than Theralink Technologies, Inc. (147.47%), less than LianBio (0.77%), less than Curative Biotechnology, Inc. (65.29%), less than BetterLife Pharma Inc. (17.44%), greater than PharmaTher Holdings Ltd. (-106.37%), less than Tristar Wellness Solutions Inc. (0%), greater than NanoSphere Health Sciences Inc. (-18.06%), greater than Glow Lifetech Corp. (-131.44%), less than ProText Mobility, Inc. (0%),
| Company | ROE | Market cap |
|---|---|---|
| -156.81% | $6.96M | |
| 147.47% | $615.15K | |
| 0.77% | $11.68M | |
| 65.29% | $8.07M | |
| 17.44% | $8.85M | |
| -106.37% | $7.92M | |
| 0% | $4.84M | |
| -18.06% | $42.13K | |
| -131.44% | $7.21M | |
| 0% | $9.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chimeric Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chimeric Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Chimeric Therapeutics Limited's ROE?
How is the ROE calculated for Chimeric Therapeutics Limited (CHMMF)?
What is the highest ROE for Chimeric Therapeutics Limited (CHMMF)?
What is the 3-year average ROE for Chimeric Therapeutics Limited (CHMMF)?
What is the 5-year average ROE for Chimeric Therapeutics Limited (CHMMF)?
How does the current ROE for Chimeric Therapeutics Limited (CHMMF) compare to its historical average?